Mixed Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Mixed Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) [Phase 3]
A Phase 3 clinical trial evaluating QLC7401 for primary hypercholesterolemia or mixed hyperlipidemia with elevated LDL-C; the study is not y…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of SYH2053 in Chinese participants with non-familial hypercholesterolemia and mixed hyper…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of SYH2053 in Chinese participants with non-familial hypercholesterolemia and mixe…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia [Phase 3]
A Phase 3 trial evaluating SHR-1209 in combination with lipid-lowering agents for hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage [Phase 3]
Phase 3 clinical trial studying SHR-1209 for primary hypercholesterolemia and mixed hyperlipidemia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Lipid Efficacy Study (0524B-022)(COMPLETED) [Phase 3]
A Phase 3 lipid efficacy trial sponsored by Merck Sharp & Dohme LLC has completed (Study 0524B-022) for primary hypercholesterolemia and mix…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) [Phase 2]
Phase 2 dose-ranging trial evaluating SCH 900271 in primary hypercholesterolemia and mixed hyperlipidemia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: A Pilot Study to Evaluate the Lipid Effects of TRIA-662 [Phase 2]
A Phase 2 pilot trial evaluating the lipid effects of TRIA-662 in hypertriglyceridemia and mixed hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) [Phase 3]
Phase 3 clinical trial update evaluating lipid efficacy and safety in participants with mixed hyperlipidemia; results posted after completio…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Lipid Efficacy/Tolerability Study (0524A-020) [Phase 3]
A Phase 3 trial evaluating lipid efficacy and tolerability (0524A-020) has completed. The study targeted primary hypercholesterolemia and mi…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: MK0859 Dose-Ranging Study (0859-003) [Phase 2]
Merck's Phase 2 dose-ranging study of MK0859 (NCT00325455) for hypercholesterolemia and mixed hyperlipidemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adding fenofibrate to atorvastatin versus atorvastatin alone in mixed hyperlipidemia; th…
-
FDA approval · 2012-12-19FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate, updating the product labeling and/or approvals under a sup…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) [Phase 1]
This Phase 1 trial evaluated whether laropiprant influences the antiplatelet effects of clopidogrel and aspirin in patients with primary hyp…